Arrowhead Pharmaceuticals vs its peers
The 10 largest Biotechnology companies by market value, prices of Nov 20, 2026
Arrowhead Pharmaceuticals is the 10th largest of the 10 biggest Biotechnology companies on OQRO by market value, at $5.85B. Its revenue of $451M in fiscal 2026 ranks 10th of 10. It runs at an operating loss of 157% of revenue, against a group median margin of 29%. Revenue fell 46% on the year before, against a median of +4.7%.
Side by side
| Company | Market value | Revenue | Growth y/y | 5-yr growth / yr | Gross margin | Operating margin | Net margin | Free cash flow margin | R&D / revenue | Price / earnings | Price / sales | FCF yield | Stock, 12 months |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AmgenAMGN · FY2025 | $236B | $36.8B | +10.0% | +7.6% | 67.2% | 24.7% | 21.0% | 22.0% | 19.8% | 30.6x | 6.4x | 3.4% |
Each company’s latest fiscal year (FY), so the years can end a few months apart. Price ratios divide today’s market value by that year’s figure; price / earnings is left out on a loss. “—” means the company did not tag that line in its annual report.
Operating margin
- UTHR47%
- EXEL38%
- VRTX35%
- GILD34%
- INCY29%
- REGN25%
- AMGN25%
- ARWR−157%
- MRNA
Compare Arrowhead Pharmaceuticals head to head
Where Arrowhead Pharmaceuticals’s revenue comes from and where it goes: Arrowhead Pharmaceuticals revenue breakdown. Twenty years of results: Arrowhead Pharmaceuticals financial history.
Common questions
Who are Arrowhead Pharmaceuticals's competitors?
The largest companies in its industry (Biotechnology) by market value: Amgen (AMGN), Gilead Sciences (GILD), Vertex Pharmaceuticals (VRTX), Regeneron Pharmaceuticals (REGN), Moderna (MRNA), Biogen (BIIB), United Therapeutics (UTHR), Incyte (INCY) and Exelixis (EXEL). They share Arrowhead Pharmaceuticals's industry listing; not every one competes with it on every product.
Is Arrowhead Pharmaceuticals bigger than Amgen?
No, by market value: Arrowhead Pharmaceuticals is worth $5.85B and Amgen $236B. By revenue, Arrowhead Pharmaceuticals brought in $451M in fiscal 2026 and Amgen $36.8B in fiscal 2025.
Where these figures come from
The group is the companies OQRO lists in the same industry as Arrowhead Pharmaceuticals (Biotechnology), the largest 9 by market value, plus Arrowhead Pharmaceuticals. Companies whose latest annual report is more than a year and a half old, or that report in a currency other than the dollar, are left out.
Revenue, operating income, net income, gross profit, research and development and free cash flow (cash from operations minus capital expenditure) are each company’s own full-year lines from its latest 10-K, as tagged in XBRL (SEC companyfacts). Market value is the last close times the shares outstanding on the latest filing. Price / earnings is market value over net income; price / sales is market value over revenue; free cash flow yield is free cash flow over market value. Five-year growth is the yearly rate that takes revenue from five fiscal years before to the latest. This page describes the past and is not investment advice. No language model wrote it.









